IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
基本信息
- 批准号:4690017
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:B lymphocyte T lymphocyte affinity chromatography biopsy cellular pathology complement pathway computer simulation cytotoxicity density gradient ultracentrifugation erythrocytes gel filtration chromatography haptens helper T lymphocyte human subject human tissue humoral immunity hypersensitivity immune adherence reaction immunofluorescence technique immunoglobulin G immunoglobulin M immunohematology immunologic assay /test immunopathology immunosuppression leukocyte activation /transformation liver cirrhosis liver disorder diagnosis liver function mixed lymphocyte reaction test monocyte orphan disease /drug phagocytosis radiation immunosuppression radioimmunoassay radiotracer reticuloendothelial system suppressor T lymphocyte surface antigens tissue /cell culture
项目摘要
Abnormal immune mechanisms are being studied in patients with primary
biliary cirrhosis (PBC). T cell mediated help and suppression of pokeweed
mitogen-induced immunoglobulin synthesis by B cells has been studied using
radioimmunoassays to measure IgG and IgM synthesized by cultures containing
appropriate mixtures of different lymphocyte subpopulations in vitro. The
ability of T cells to proliferate when cultured with either autologous or
allogeneic irradiated B cells (mixed lymphocyte reactions) or with
hapten-modified autologous irradiated B cells has been assessed. Results
of these studies include the demonstration in PBC of (i) a diminished
capacity of T cells to inhibit immunoglobulin synthesis in vitro, (ii) a
deficiency of the autologous but not the allogeneic mixed lymphocyte
reaction and (iii) a deficiency in the primary but not the secondary
proliferative response of T cells to hapten-modified cells. These findings
suggest that in PBC there is a fundamental defect in the interaction
between autoreactive T cells and surface antigens on autologous non-T cells
which leads to diminished activation of suppressor T cells and, hence,
predisposes to a state of immune hyperresponsiveness. The coexistence of
IgA deficiency and PBC has been documented. Thus, while it is possible
that IgA deficiency may contribute to the development of PBC, the
pathogenesis of PBC does not require IgA-dependent mechanisms. Sera from
patients with PBC has been shown to contain a factor, probably an
abnormally immunoreactive IgM, which blocks the binding of C3b-opsonized
erythrocytes by monocytes; this finding affords a potential explanation for
the C3b-receptor specific clearance defect by fixed macrophages in PBC.
Patients with PBC have been shown to have diminished natural killer cell
activity due to a functional defect of cytolytic effector cells. Defects
of humoral immunity in PBC appear to be due to activation of small
subpopulations of B cells. For example, in PBC there is evidence
compatible with an expanded clone of B cells that synthesize mitochondrial
antibodies with different antigenic specificities from those synthesized by
normal B cells. A disease-specific immunologic defect has yet to be
defined in PBC.
正在对原发性癌症患者的异常免疫机制进行研究
胆汁性肝硬化(PBC)。 T 细胞介导的商陆帮助和抑制
已使用 B 细胞研究了有丝分裂原诱导的免疫球蛋白合成
放射免疫测定法测量含有以下成分的培养物合成的 IgG 和 IgM
体外不同淋巴细胞亚群的适当混合物。 这
T 细胞与自体或自体培养物一起培养时的增殖能力
同种异体辐照 B 细胞(混合淋巴细胞反应)或
已对半抗原修饰的自体照射 B 细胞进行了评估。 结果
这些研究包括在 PBC 中证明 (i)
T 细胞在体外抑制免疫球蛋白合成的能力,(ii)
自体混合淋巴细胞缺乏,同种异体混合淋巴细胞不缺乏
反应和(iii)主要缺陷而不是次要缺陷
T 细胞对半抗原修饰细胞的增殖反应。 这些发现
表明 PBC 的相互作用存在根本性缺陷
自身反应性 T 细胞与自体非 T 细胞表面抗原之间的关系
这会导致抑制性 T 细胞的激活减少,因此,
容易进入免疫高反应状态。 共存
IgA 缺乏症和 PBC 已被记录。 因此,虽然有可能
IgA 缺乏可能会导致 PBC 的发生
PBC的发病机制并不需要IgA依赖性机制。 血清来自
PBC 患者已被证明含有一个因素,可能是
异常免疫反应性 IgM,可阻断 C3b 调理素的结合
红细胞由单核细胞组成;这一发现提供了一个潜在的解释
PBC 中固定巨噬细胞的 C3b 受体特异性清除缺陷。
PBC 患者的自然杀伤细胞数量减少
由于溶细胞效应细胞的功能缺陷而导致的活性。 缺陷
PBC 中体液免疫的减弱似乎是由于小
B 细胞亚群。 例如,PBC 有证据表明
与合成线粒体的 B 细胞扩增克隆相容
与合成的抗体具有不同的抗原特异性
正常B细胞。 疾病特异性免疫缺陷尚未确定
在 PBC 中定义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E ANTHONY JONES其他文献
E ANTHONY JONES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E ANTHONY JONES', 18)}}的其他基金
STUDIES OF ALPHA-1-ANTITRYPSIN PHENOTYPES AND METABOLISM
ALPHA-1-抗胰蛋白酶表型和代谢的研究
- 批准号:
3941102 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY & HEPATIC FAILURE
肝性脑病发病机制的相关研究
- 批准号:
3840476 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES OF RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY
肝性脑病发病机制的相关研究
- 批准号:
3918247 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




